Evotec is an integrated drug discovery, preclinical development, and manufacturing platform that serves pharmaceutical and biotechnology companies, academic institutions, and foundations through a full-service research and development value chain. The company generates revenue primarily through fee-for-service and full-time equivalent arrangements with clients spanning oncology, central nervous system disorders, cardiovascular-renal disorders, immune and inflammatory diseases, and other therapeutic areas, complemented by royalties and milestone payments on partnered assets. Evotec differentiates itself through proprietary technologies including AI-driven innovation, molecular patient databases, induced pluripotent stem-cell disease modeling, and omics platforms, along with manufacturing capabilities that enable it to offer integrated chemistry, biology, and manufacturing services across multiple drug modalities from discovery through early clinical development.